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Corneodesmosin (CDSN) is a desmosomal protein expressed in the epidermis during the late stages of
differentiation and in the inner root sheath of hair follicles. The homophilic adhesive properties of the protein
suggest that it reinforces keratinocyte cohesion in the upper layers of the epidermis (stratum granulosum and
stratum corneum). In this study, we analyzed the expression of the CDSN gene in 16 human tissues. We conﬁrmed
the closely restricted expression pattern of CSDN. Indeed, apart from the skin, the mRNA was signiﬁcantly detected
only in the placenta and the thymus. As a step in elucidating the mechanisms of tissue-speciﬁc expression,
transgenic mice bearing a 4.2 kb fragment of the human CSDN gene promoter linked to the LacZ gene were
generated. The reporter-gene expression was detected in special areas of the inner root sheath of the hair follicles
and the hair medulla but not in the epidermis. Induction of epidermis hyperproliferation however either by
pharmacological agents or by wounding led to strong expression of the reporter gene in the keratinocytes of the
stratum granulosum and the parakeratotic corneocytes of the stratum corneum. The data suggest that the genomic
sequences and/or regulating factors responsible for the cell-speciﬁc expression of the human CDSN gene in the
normal hair follicle as well as in the hyperproliferative epidermis are different from those necessary for expression
in the normal epidermis.
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Corneodesmosin (CDSN) was initially identified as a protein
specifically expressed in the cornified squamous epithelia
by means of monoclonal antibodies. Moreover, CDSN was
demonstrated to be a desmosomal component that dis-
plays the unique feature of being a secreted, extracellular
protein (Serre et al, 1991; Guerrin et al, 1998). In the
epidermis, CDSN is synthesized by the granular layer
keratinocytes that correspond to the last step of the
terminal differentiation of the living keratinocytes before
cornification (Serre et al, 1991). Immuno electron micro-
scopic studies revealed that after its secretion by specia-
lized vesicles, the keratinosomes, CDSN was detectable in
the extracellular part of the desmosomes of the keratino-
cytes of the stratum granulosum. Furthermore, the protein
was also detected in the corneodesmosomes, structures
derived from the desmosomes in the course of cornification.
Here, it is assumed to be involved in cohesion of the
cornified layers (Haftek et al, 1991; Serre et al, 1991).
Indeed, expression of a chimeric molecule comprising the
CDSN sequence fused to the transmembrane and intracel-
lular domains of E-cadherin at the surface of mouse
fibroblasts confers interadhesive properties to the cells.
Moreover, recombinant CDSN displays homophilic interac-
tions evidenced by overlay binding assay (Jonca et al,
2002). As CDSN most probably contributes to epidermal
cohesion, it seems very likely it is also involved in the
epidermal barrier function. The desquamation process must
imply the disruption of the corneodesmosomal links. We
precisely described the various steps of proteolysis of
CDSN during stratum corneum formation and maturation,
leading to CDSN fragments most probably devoid of
adhesive properties (Lundstro¨m et al, 1994; Simon et al,
1997, 2001). Taken together, these data strongly suggest
that CDSN is essential for epidermal cohesion and that its
proteolysis is a prerequisite for desquamation.
Immunofluorescence studies showed that CDSN is
expressed in the epidermis as well as sequentially in the
three layers of the inner root sheath (IRS), in which the onset
of its expression occurs consecutively in the Henle layer, the
Huxley layer, and finally in the cuticle of the IRS (Serre et al,
1991). A similar expression pattern was evidenced in pig,
guinea-pig, rat, and mouse hair follicles (Monte´zin et al,
1997). In humans, a pericellular location of CDSN in the IRS
was previously shown by indirect immunofluorescence
(Serre et al, 1991). Its probable desmosomal location (as
shown for the epidermis), however, remains to be confirmed
by immuno electron microscopy.
The CDSN gene is a candidate in genetic susceptibility to
psoriasis vulgaris consequently to its location on chromo-
some 6p21.3 (Zhou and Chaplin, 1993) in PSORS1, the
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major locus for susceptibility to familial psoriasis (for a
review, see Capon et al, 2002). Moreover, various analyses
have revealed a genetic association between CDSN and the
susceptibility to psoriasis (Allen et al, 1999; Jenisch et al,
1999; Tazi Ahnini et al, 1999; Schmitt-Egenolf et al, 2001;
Capon et al, 2003).
Very recently, nonsense mutations in the coding region of
the CDSN gene were shown to be responsible for an
autosomal dominant form of non-syndromic alopecia,
hypotrichosis simplex of the scalp, in three families (Levy-
Nissenbaum et al, 2003). Histological analyses revealed the
presence of abnormal hair follicles. Moreover, amorphous
material, most probably containing the product of the
disease allele but not the intact full-length protein, was
present in the superficial dermis. These data underscore the
role of CDSN in the growth and maintenance of scalp hair.
In this study, we confirmed the closely restricted
expression pattern of human CDSN in mice for the first
time. As a step towards elucidating the mechanisms of
tissue-specific gene expression, we generated transgenic
mice bearing a 4.2 kb fragment of the human CDSN
promoter linked to the LacZ reporter gene. Reporter gene
expression was only found in specific structures of the hair
follicles; however, induction of hyperproliferative conditions
by pharmacological agents or wounding led to strong
expression of the transgene in the epidermis. These data
demonstrate that the genomic segment analyzed contains
the promoter sequences required to drive cell-specific
expression of the human CDSN, both in the normal hair
follicle and in the hyperproliferative epidermis. The absence
of LacZ expression in the normal epidermis is discussed.
Results
Analysis of CDSN mRNA expression in human adult
tissues The expression of CDSN mRNA in the epidermis
was clearly evidenced by RT-PCR using cDNAs prepared
from micro-dissected skin of normal human adult (Fig 1a).
In order to compare CDSN expression in various tissues,
we used commercial multiple tissue cDNA panels and the
epidermal cDNAs appropriately diluted to get equivalent
signals for the G3PDH control cDNA (Fig 1b). With the
various cDNAs tested, besides that from the epidermis, a
significant signal was only detected in the placenta and,
albeit weak, in the thymus and the testis (Fig 1a). As a first
step in characterizing the regulatory sequences that direct
site-specific CDSN expression in such a specific manner,
we analyzed the human CDSN promoter in transgenic mice.
Analysis of the human CDSN gene upstream sequence
and comparison with the murine sequence The sequen-
cing of the 4.2 kb upstream CDSN fragment cloned from
cosmid ICRFc109cN1042QD2 revealed 22 nucleotide dif-
ferences with the human BAC AB023060 sequence that
might correspond to polymorphism. Starting from the first
CDSN ATG codon of the BAC sequence (position 28558),
the putative polymorphic sites are the following: T/C 28552;
T/C 27832; C/G 27715; A/– 27535; C/G 27364; C/T 27363;
G/– 27334; G/C 27157; A/G 27121; –/A 26499; A/G 26464;
A/G 26462; A/– 26449; C/T 26200; G/A 26154; A/C 25910;
–/A 25769; G/A 25683; T/C 25425; C/– 25557; T/C 24581;
T/C 24629. The CDSN transcription start site has been
experimentally determined at position nt 14 relative to the
first ATG codon (Zhou and Chaplin, 1993). Analysis of the
1.5 kb genomic DNA sequence immediately upstream of
the first ATG codon using the ‘‘Neural Network Promoter
prediction’’ tool (http://www.fruitfly.org/seq_tools/promoter.
html) indicated a TATA-box-like sequence (CATAAA) at
position 57 relative to the first ATG codon and proposed
a transcription start site at position 27. Moreover, the only
human spliced 50 EST starts at the same position (Genbank
AU134804). Therefore, exon 1 from the human CDSN is
most likely 13 nt longer in the 50 direction than experimen-
tally determined, although we cannot exclude the existence
of two transcription start sites.
A blast search with the human CDSN cDNA sequence
allowed us to localize the corresponding murine gene in
BAC AF111103. A dot-plot analysis of 20 kb of this
sequence with that of the human BAC AB023060 revealed
blocks of conserved sequences, two of them corresponding
to the CDSN exons 1 and 2 (Fig 2a). According to the
present human genome annotation, the CDSN gene is
embedded in an intron of the SEEK 1 gene, transcribed
from the opposite strand, that encodes a putative transcrip-
tion factor. Moreover, the human CDSN gene is located
Figure1
Expression of CDSN transcripts in adult human tissues by RT-PCR.
The multiple tissue cDNA panels I and II (Clontech) were used as PCR
templates. The cDNAs had been derived from polyAþ -RNA isolated
from the adult tissues as indicated (PBL: peripheral blood leukocytes),
and normalized by the supplier against the transcripts of several
housekeeping genes. PCR products were analyzed after 35 (a, CDSN)
or 25 (b, G3PDH) cycles. (a) CDSN transcripts are detected as a PCR
fragment of 1875 bp in the epidermis, placenta, thymus and very poorly
in the testis. M: ‘‘1 kb Plus DNA Ladder’’ (Invitrogen Life Technologies,
Cergy Pontoise, France), (b) Amplification of G3PDH cDNA reveals a
similar signal in the different lanes. : PCR reaction performed in the
absence of cDNA. 50- and 30-epidermis lane: PCR amplification of
epidermis cDNA synthesized using either a 30-poly(T) primer (30) or a 50-
internal primer (50).
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approximately 3.3 kb upstream of the STG gene, tran-
scribed from the same strand and encoding a putative
secreted protein with unknown function. The dot-plot
analysis, and a blast alignment of the human and mouse
genomic sequences (data not shown) however revealed
that the two exons of the STG gene are not conserved and
that the first three exons of the SEEK1 gene that mostly
contain 50UTR sequences are, at best, very poorly con-
served. Sequences conserved between human and mouse
genome (excluding CDSN exons) evidenced by the dot-plot
analysis might thus participate in the regulation of CDSN
expression.
To analyze in more detail potential regulatory sequences,
the human and mouse genomic segments analyzed in Fig
2a were submitted to PipMaker analysis (Schwartz et al,
2000). As shown in Fig 2b, the two CDSN exons were
the most conserved. Upstream of exon 1, four blocks of
significant homology were further visualized in the 9.2/
8.3 kb, 6.8/4.5 kb, 3.2/2.6 kb, and 1.5/0 kb
segments. Both the 50 and 30 ends of the intron, as well as
the 1.2 kb segment downstream of the gene, also displayed
significant homology (Fig 2b). Of note was a 151 nt portion
in the intron, with 82% identity between human and mouse
genes. Moreover, the -120/-1 nt segment (relative to the
predicted cap) was 88% conserved.
Generation of transgenic mice Transgenic mice were
generated with a cassette containing 4.2 kb of the human
CDSN upstream sequence and its 50UTR fused to the LacZ
gene containing a nuclear localization signal (Fig 3a).
Twenty-five mice were screened for b-gal (Fig 3b) and
human CDSN sequences (data not shown). The F1 offspring
of the positive founder mice (four) were screened for the
presence of the transgene by PCR (Fig 3c).
Histological analyses of the transgene expression were
first performed on the back skin of animals of the four
transgenic lines. Altogether, 60 animals were analyzed,
aged between 2.5 d and more than 3 mo (line 8, 14 animals;
line 16, seven animals; line 18, six animals; line 21, 33
animals). The pattern of transgene expression was identical
in the four transgenic mice strains, suggesting that it was
dictated by the CDSN regulatory sequence rather than by
transgene integration sites. The transgene expression level
however, differed quantitatively between the different lines,
increasing from lines 18, 16, 8 to 21 (data not shown).
The human 50-upstream 4.2 kb CDSN sequence com-
pletely failed to direct sustained reporter gene expression in
the mouse epidermis in any of the four mouse lines after
enzymohistological analysis performed on pre-fixed tissue
fragments (Fig 4a). The absence of significant b-galactosi-
dase activity in the normal epidermis was confirmed by a
sensitive chemiluminescent reporter gene assay (Galacto-
Light Plus, TROPIX, Bedford, MA) (data not shown). Indeed,
the expression of the transgene was fully restricted to the
whisker and body hair follicles (Figs 4 and 5). Here, the
reporter-gene activity is clearly seen in the nuclei of the cells
of the Henle and Huxley layers (Figs 4b–g and 5), thus
resembling the endogenous CDSN expression in human
hair follicles (Mils et al, 1992). Looking in more detail, the
nuclear reporter-gene signals are clearly located in that part
of the Henle layer where Henle cells begin to differentiate
terminally. In the Huxley layer it can be detected in the
Figure 2
Comparison of the human and murine CDSN
genomic regions and localization of potential
transcription factor binding sites on the hu-
man CDSN gene upstream region. (a) Dot-
plot analysis performed with the DNA Strider soft-
ware (Marck, 1988). The human sequence
corresponds to nt 18533–39196 of GenBank file
AB023060, and the murine sequence to nt
108033–128700 of file AF111103. The position
of the exons from the human genes CDSN,
SEEK1, and STG is as annotated in the UCSC
Genome Browser (Kent et al, 2002). The position
of mouse CDSN exons is that of the predicted
gene SMUST00000044804 (UCSC Genome
Browser; chr17:34640057–34645227), although
several EST predict that mouse CDSN exon 2
might be longer than its human ortholog. (b)
Alignment of the human and murine CDSN genes
by PipMaker (Schwartz et al, 2000). The se-
quences analyzed are the same as for (a), the
human sequence being used as reference (upper
line). The percentage identity between human
and mouse sequences is indicated by dots when
higher than 50%. Nearby dots lead to small bars.
The scale is indicated on the right. The location
of the repeated sequences as analyzed by
PipMaker was omitted. The heavy line under
the panel indicates the human genomic segment
fused to the LacZ gene to generate transgenic
mice.
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upper part, again, beginning at the point where Huxley cells
terminally differentiate. The CDSN-LacZ transgene how-
ever, as evidenced by X-gal staining, was expressed in the
nuclei of only a portion of CDSN-expressing cells. A similar
phenomenon was previously reported for several epidermal
transgenes and was tentatively attributed to a rapid
degradation of b-galactosidase in keratinocytes (Takahashi
and Coulombe, 1997). Moreover, the scattering of nuclear
staining may also be due to a loss of nuclei during tissue
sectioning or to nuclei lying outside the section plane.
Despite considerable efforts to evidence b-galactosidase
expression in the cuticle of the IRS, this point remains
uncertain due to the extreme thinness of this layer in mice.
Surprisingly, the transgene was also strongly expressed in
the mouse hair medulla (Fig 5f–i). This prompted us to
examine more precisely the expression of endogenous
CDSN in mouse and human hair medulla. In contrast to a
previous study (Serre et al, 1991), CDSN expression was
clearly detected in the medulla cells of mouse body hair
(Fig 6a–c). In summary, the transgene expression para-
lleled human and mouse CDSN expression in hair follicles,
demonstrating that, in the construct, the sequences
sufficient for directing hair follicle expression are present.
Besides the epidermis, other squamous epithelia (i.e.,
tongue, esophagus, and buccal mucosa) examined, includ-
ing cornified epithelia, were negative for transgene expres-
sion (data not shown). In addition, no transgene expression
was detected in mouse spleen, thymus, heart, kidney, liver,
and placenta (data not shown). This indicates that the
50-upstream CDSN sequence specifically governs LacZ
gene expression in one of the major expression sites of
endogenous CDSN.
To assess whether the CDSN promoter is inducible in
vivo, TPA was applied on the dorsal skin of adult mice. The
hyperproliferative epidermal response induced after 48 h
was associated with an increase in endogenous CDSN
expression (Fig 7a, b). In parallel, reporter-gene expression
was detected in granular keratinocytes as well as in
parakeratotic corneocytes (Fig 7c) for mouse lines 8, 16,
and 21 (line 18 not tested). Similar results were obtained
after topical treatment of adult mice from lines 8 and 21 with
Figure 3
Generation of CDSN/b-Gal transgenic mice. (a) Diagram of the
construct used for microinjection. The transgene encompasses 4.2 kb
of the human CDSN upstream sequences and the 50UTR region
modified to introduce an Nco I restriction site at the translation initiation
codon and the LacZ coding sequence with a nuclear localization signal.
(b) Southern blot analysis of founder lines with a Dig-labeled LacZ
probe. Genomic DNA (10 mg per lane) was analyzed after BamH1
digestion. Lines 8, 18, and 21 are transgenic. The fourth positive line,
line 16 is not illustrated here. M: Mr marker VII (Roche Meylan, France).
(c) PCR analysis of founder mouse 8 progeny. Lanes 1, 3, and 5:
transgenic animals. Lanes 2 and 4: non-transgenic animals. Lane 6:
PCR reaction in the absence of genomic DNA. Arrow: amplification
product of lacZ transgene (822 nt); arrowhead: amplification product of
the endogenous SYN-RAP gene (590 nt).
Figure 4
In situ analysis of b-galactosidase expression
in the skin of transgenic mice (line 21).
Although endogenous CDSN is synthesized in
the epidermis, there is no detectable signal at
this site (ep; a); however, the signal is present in
the IRS of the body hair follicles (arrows; a). The
CDSN promoter is active in the IRS Henle layer in
the lower part of the hair follicle (He; b, c and
cross-sections in d, e). In the upper follicle
portion, expression is detectable in the Huxley
layer (Hu; B, C and cross-sections in F, G). Note
the arched growth of the hair in (b) seen by the
near longitudinal and near-cross-section of the
same hair and cross-sections through the lower
(c, right) and upper (c, left) parts of the same
follicle. co, cortex; dp, dermal papilla. Hematox-
ylin counterstaining and bright-field microscopy.
Scale bars: 20 mm.
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retinoic acid, i.e., an increase in endogenous CDSN
expression associated with an induction of b-galactosidase
activity in the epidermis (Fig 7d–f ).
Unpublished results from our lab have shown that CDSN
expression is upregulated in the course of cutaneous
wound healing in the pig. This prompted us to analyze
mouse endogenous CDSN as well as transgene expression
under such conditions. As expected, injuries in the skin of
adult mice resulted in an increase in CDSN expression
evidenced in the hyperproliferative part of the epidermis at
the proximal edges of the wound (Fig 8a) as well as in the
adjacent hair follicles (data not shown). In parallel, LacZ
expression was detected in the epidermis of lines 8, 18,
and 21 (Fig 8b). More precisely, b-galactosidase activity
occurred in suprabasal cells of the newly formed epithelium
proliferating under the scab during the healing process (Fig
8b, inset). A strong increase in transgene expression was
also detected in the hair follicles close to the site of injury
(Fig 8c). Both induced endogenous CDSN and transgene
expressions were detected as early as the 24 h after injury
(data not shown). Thus, this observation establishes that the
critical information required to mediate induction following
injury is contained in the proximal 4.2 kb 50-upstream
sequence of the human CDSN gene.
Discussion
Previous immunohistological analyses of CDSN expression
in humans indicated that the protein is present in the upper
layers of the cornified squamous epithelia such as the
epidermis, but is absent from the non-cornified squamous
epithelia of the vagina, uterine cervix, or esophagus
epithelium. Moreover, no expression could be detected in
the epithelia of the bladder or trachea either (Serre et al,
1991). Among 16 tissues examined, RT-PCR revealed a
significant presence of human CDSN mRNA only in the
placenta and thymus. In agreement with these results, a
high expression of CDSN mRNA in human placenta, as
compared to 46 other human tissues or cell lines, is
mentioned in the GNF site (Gene Expression Atlas, http://
expression.gnf.org/cgi-bin) based on Affimetrix technology
(squamous epithelia not analyzed). Both RT-PCR experi-
ments and immunohistological analyses of mouse placenta
at embryonic days E12.5 and E15.5, however, failed to
Figure 5
Expression of the transgene in mouse body and whisker hair
follicles (line 21). Enzymatic activity is clearly detected in the IRS
Henle layer (He) of the lower follicle region (a, cross-sections in d, e)
and in the Huxley layer (Hu) of the upper follicle portion (a, cross-
sections in b, c). Signals are also seen in the medulla (med) of whisker
hairs (wh; h, i) and of body hairs (bh; f-h). Note the prominent medulla in
whiskers. co, cortex. Differential interference contrast microscopy
(DIC). Scale bars: 20 mm.
Figure6
Expression of CDSN in mouse and human hair medulla cells.
Immunohistological staining of mouse and human hairs was performed
with F28-27 anti-CDSN antibody. Paraffin-embedded sections of
mouse back skin analyzed with anti-CDSN antibody reveal strong
labeling of the IRS as well as labeling of medulla cells on longitudinal (a)
and transversal hair sections (b). Near-longitudinal cryosections of a
human hair follicle of the scalp analyzed by indirect immunofluores-
cence show strong labeling of the IRS cells, and a microgranular
cytoplasmic labeling of the medulla cells (c). In controls, where parallel
sections were reacted with the primary control MOPC-21 antibody, no
significant immunoreactivities were observed (data not shown). Scale
bars: 20 mm.
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detect any CDSN expression (data not shown). This
discrepancy between human and mouse CDSN gene
expression in the placenta might constitute an interspecies
difference, but could also be due to changes in CDSN
expression in the different stages during placental devel-
opment. Moreover, the presence of the protein in the human
placenta remains to be confirmed.
On the contrary, expression of CDSN in Hassall’s
corpuscles from the human and mouse thymus was
confirmed by immunohistology (data not shown). This
observation is in line with numerous analogies between
the thymus epithelium and epidermis. In particular, the
thymus corpuscles that represent the final stage in the
maturation of thymic medullary epithelium (Franke et al,
1979; Heid et al, 1988; Nicolas et al, 1989) express keratins
characteristic for the highly differentiated keratinocytes of
the suprabasal layers of the epidermis (Laster et al, 1986)
and other proteins found at this differentiation stage like
desmocollin 1 (Nuber et al, 1996) or calcineurin A and B
(Nishio et al, 2000).
As a first step in analyzing the CDSN promoter,
transgenic animals were generated with the 4.2 kb 50-
flanking fragment and the 50UTR, linked to the E. coli LacZ
gene. The progeny of four transgenic lines revealed that this
transgene was restrictively expressed in distinct compart-
ments of the hair follicles, but was absent from any other
tissues examined, including the epidermis, placenta, and
thymus. In the hair follicles, expression of the transgene
paralleled that of endogenous CDSN expression in mice
and humans. Our results demonstrate that the promoter
sequences sufficient to direct CDSN expression in the hair
follicle are contained within the 4.2 kb upstream gene
fragment. This fragment therefore represents an interesting
tool for driving protein expression in specific hair follicle
compartments. We previously reported that CDSN is
expressed in the three layers of the IRS (Serre et al,
1991). Here we provide the first evidence of CDSN
expression in the mouse and human hair medulla cells.
The hair medulla and IRS cells share common features in
several aspects. The presence of non-membrane-bound
droplet inclusions (‘‘eleidin’’) in their cytoplasm has long
been described (Voerner, 1903). Trichohyalin was later
identified as the major component of these granules
(Rothnagel and Rogers, 1986; O’Keefe et al, 1993). Like
trichohyalin, CDSN is expressed in both the medulla and
IRS. Moreover, trichohyalin is also expressed in epidermal
granular keratinocytes (Hamilton et al, 1991). Thus, both
proteins share common expression sites. Whether the two
gene promoters also share common regulatory transcription
factors remains to be determined; however, an alignment of
the two proximal promoter sequences (1 kb) performed
using the ‘‘Blast’’ algorithm failed to detect any striking
sequence homology.
This first report of the presence of CDSN in hair medulla
cells could give new insight regarding the understanding
of the phenotype of patients suffering from non-syndromic
alopecia associated with premature stop codons in
the CDSN gene (Levy-Nissenbaum et al, 2003). As the
presence of a medulla is less restricted to scalp hairs than
to secondary, sexual hairs (beard, pubic, etc.), this would
not explain why the disease is restricted to the scalp.
Figure 7
Induction of endogenous CDSN and transgene expression after
TPA or retinoic acid treatment (line 21). Topical TPA treatment
induces an epidermal hyperproliferative response obvious after 48 h (b)
as compared with untreated skin areas of the same animal (a).
Immunohistological analysis using anti-CDSN antibody shows that the
expression of CDSN is strongly upregulated. In parallel, expression of
the CDSN transgene is clearly detected in the upper layers of the
hyperproliferative epidermis (c). Similar results were obtained after
topical retinoic acid treatment for 3 d, i.e., induction of CDSN
expression (e) as compared with a control from the same mouse (d)
and induction of the transgene expression (f). Scale bars: 20 mm.
Figure 8
Induction of endogenous CDSN and CDSN-transgene expression
in the course of wound healing (line 8). Adult transgenic mice were
submitted to skin injury and euthanized after 72 h. Skin fragments were
analyzed for CDSN expression after paraffin embedding (a) and for
b-galactosidase activity after either paraffin embedding (b) or cryosec-
tion (c). The area of the scab is represented by brackets. The process of
re-epithelialization after injury is associated with overexpression of
CDSN, mainly at the edge of the wound (a). Expression of the CDSN-
transgene is evidenced in similar areas, at the proximal edge of the
wound (b). The insert shows that b-galactosidase expression occurs in
the most differentiated keratinocytes of the neoepithelium as well as in
the parakeratotic corneocytes. Injury also induces an increase of
transgene expression in the hair follicles close to wound edges
(c). Scale bars: 20 mm.
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Therefore, the phenotypes observed in non-syndromic
alopecia might be more probably caused by the defects in
the IRS.
The absence of transgene expression in the epidermis of
the mouse could be due to the absence of enhancer
sequences in the promoter fragment used. These se-
quences could be located in the intron that displays highly
conserved regions at both extremities. Alternatively, the lack
of promoter activity in the epidermis could be related to
differences between human and mouse genomic se-
quences and/or enhancer factors. Indeed, it is conceivable
that the sequence motif required for expression in normal
human epidermis is present in the 4.2 kb sequence, but the
mouse factor responsible for such expression could not
interact with this motif. In any case, the restriction of
transgene expression to the hair follicle indicates that the
human sequences (and/or mouse binding factors) required
for normal epidermal and hair follicle expression in the
mouse model are different.
AP-1 subunits expressed in the keratinocytes are
thought to be predominantly involved in the regulation of
the differentiation program. AP-1 target genes in the
epidermis include numerous suprabasally expressed genes,
e.g., TGM1, LOR, IVL, FLG (Angel et al, 2001). It is well
established that gene induction by TPA is mediated by AP-1
sites. We show here that TPA also induces mouse CDSN
overexpression. The human CDSN proximal promoter
displays conserved binding sites for AP-1 factors that might
mediate induction of the transgene; however, these sites are
not sufficient to direct transgene expression in normal
mouse epidermis. Topical TPA application induces profound
modifications of epidermal proliferation and differentiation
programs that share features with those observed after
retinoic acid application or during wound healing (hyper-
acanthosis, parakeratosis, and hyperkeratosis). Under
these conditions, we show that the endogenous CDSN
mouse gene is upregulated and that, in parallel, the
transgene is strongly expressed even though it is not
transcribed in the normal mouse epidermis. This means that
the response to injury is mediated by elements that can
efficiently activate our construct. These results suggest that
induction of CDSN in the course of this alternative
epidermal differentiation program depends on sequences
(and/or enhancer factors) different from those that direct
CDSN in the normal epidermis.
Several growth factors and cytokines play an impor-
tant role in the repair process. Release of interleukin-1 is
thought to be the initiator of keratinocyte activation,
resulting in activation of transcription factors, such as
NFkB, C/EBPb, ATF2, and AP-1, and production of
additional growth factors and cytokines, including inter-
leukin-6, TNF-a and members of the EGF family (for a
review, see Freedberg et al, 2001). Moreover, interleukin-1
directly induces the synthesis of keratin 6, modifying the
keratinocyte cytoskeleton (Komine et al, 2001). It is
tempting to speculate that overexpression of CDSN, a
desmosomal protein, is part of keratinocyte cytosketelon
modifications following cutaneous injury. Future investiga-
tions need to be performed to identify the cytokines and
growth factors that participate in the regulation of CDSN
expression.
Materials and Methods
PCR analysis of multiple tissue cDNA panels Two human
multiple tissue cDNA panels (MTC panels I and II) obtained from
Clontech were used as templates for PCR analysis, according to
the supplier’s instructions. Glyceraldehyde-3-phosphate dehydro-
genase (G3PDH) control primers provided by the manufacturer
(amplification of a 983 bp fragment) were used in a 25-cycle
reaction. Primers designed in the two exons of CDSN, to avoid any
amplification of genomic DNA, as described (Guerrin et al, 2001),
were used under standard PCR conditions (35 cycles). Poly(A)þ
RNA extracted from the human epidermis as reported (Guerrin
et al, 1998) and reverse transcribed using 50- and 30-SMART RACE
primers (Clontech Palo Alto, CA, USA) was used as a positive
control. The human epidermis was obtained from patients under-
going plastic surgery after informed consent and in accordance
with Helsinki statements.
Constructs and transgenic mice The CDSN upstream region
was isolated by screening a Lawrist 4 cosmid library (Nizetic et al,
1994) with a [32P]-labeled CDSN cDNA probe (nt 52–583,
AF030130). Seven clones were purchased as IMAGE clones from
the RZPD and analyzed by Southern blotting and restriction
mapping. A 4.6 kb Xba I fragment, including 4.2 kb of the CDSN
upstream sequence, the first exon, and 0.3 kb of the intron, was
isolated from clone ICRFc109cN1042QD2, cloned in pUC18, and
sequenced. Mutagenesis of the sequence surrounding the ATG
translation initiation codon in the first exon was performed to
create an Nco I site. An Nco I fragment of the resulting plasmid,
extending to nt 222 relative to the ATG, was cloned at the unique
Nco I site of the pnLacF vector (Mercer et al, 1991) so that the ATG
initiation codon of CDSN was replaced by that of the LacZ gene.
Then, the Xba I/Xho I fragment of CDSN (nt 4244/37) was
inserted between the unique Xba I site of pnLacF and the Xho I site
(nt 37) of the CDSN gene. The transgene was excised from the
plasmid vector, purified by agarose gel electrophoresis and DNA-
isolation columns (Qiagen), and microinjected into single-cell B6/
CBA mouse embryos. Founders were identified by Southern
blotting of tail genomic DNA using a Dig-labeled probe (Roche)
for the coding region of LacZ. Littermate screening was performed
by multiplex PCR using tail DNA and primers for the LacZ gene and
for the mouse RAP-SYN gene as internal control, as described
(Hanley and Merlie, 1991).
Histological analyses
Histoenzymology Tissue fragments were prefixed for 90 min on ice
in PBS (pH 7.4) containing 2% p-formaldehyde, 0.2% glutaralde-
hyde, 0.02% NP40, 0.01% sodium deoxycholate and washed
twice in PBS containing 2 mM MgCl2, 0.02% NP40 and 0.01%
sodium deoxycholate. The incubation in X-Gal solution (5-bromo-
4-chloro-3-indolyl b-D-galactoside, Sigma, St. Louis, MO, USA)
was performed on prefixed tissue fragments, overnight at 371C,
as previously done for other epidermis genes (Takahashi and
Coulombe, 1997). Reducing the incubation length to 6 h or the
temperature to 301C led to basically identical results. After
incubation in X-Gal solution, samples were directly frozen in liquid
nitrogen-cooled isopentane, or paraffin embedded after post-
fixation. Sections (5–7 mm) were either counterstained using
nuclear red or hematoxylin, or directly examined using differential
interference contrast microscopy.
Immunohistology Mouse tissue fragments were fixed in Bouin’s
solution and embedded in paraffin. Sections (6 mm) were incubated
with mouse monoclonal antibody F28-27 (against CDSN, Serre
et al, 1991) or MOPC-21 as control (Sigma), both diluted to 2 mg
per mL. The bound primary antibody was detected using the
immunoperoxidase detection method (Histomouse SP Kit, Zymed
San Francisco, CA, USA). In parallel, fragments of human scalp
obtained from patients undergoing plastic surgery were promptly
frozen in liquid nitrogen-cooled isopentane. Immunohistochemistry
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was performed on cryosections by indirect immunofluorescence
as previously reported (Serre et al, 1991). The F28-27 antibody was
diluted to 2.5 mg per mL and fluorescein-conjugated goat anti-
mouse IgGs (Southern Biotechnology Associates, Birmingham, AL,
USA) were used as secondary antibodies, diluted to 5 mg per mL.
Wound-healing experiments Adult transgenic mice were anesthe-
tized, shaved and an incision was performed in the dorsal skin
using a sterile blade. The animals were euthanized after 24, 48, or
72 h. Pieces of injured skin were analyzed for b-galactosidase
activity and CDSN expression.
Topical treatments Under anesthesia, the back skin of adult
transgenic mice was shaved and skin biopsies were taken for
control analyses. All-trans-retinoic acid was applied daily for 3 d
(200 mL of a 0.25 mM solution in acetone) and the animals
were euthanized on the fourth day. Alternatively, application of
12-O-tetradecanoylphorbol-13-acetate (TPA) was done topically
once (200 mL of 50 nM TPA in ethanol). The animals were
euthanized 48 h later. Controls consisting in topical application of
the vehicles on transgenic animals from the same littermates under
the same conditions did not reveal any effects (data not shown).
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